Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. entered into a private investment in public equity (PIPE) agreement on September 11, 2026, to issue 1,080,000 Class A ordinary shares at $2.75 per share to non-U.S. investors. The transaction resulted in aggregate gross proceeds of approximately $2.97 million, with investors receiving warrants to purchase up to 1,845,452 additional shares exercisable over five years.…more
Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology terminated its independent auditor, WWC, P.C., effective September 1, 2026, and appointed HTL INTERNATIONAL, LLC as its new auditor. The company confirmed that there were no disagreements regarding accounting principles or auditing scope, and the previous auditor's reports contained no adverse opinions or modifications.…more
Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd.에 대하여 Meng Hao(Mike)가 대량지분 보유 현황을 보고하는 Schedule 13G 공시를 제출하였습니다. 해당 공시는 특정 투자자의 지분율 변동 및 보유 목적을 공식화하는 절차입니다.…more
14 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
No news collected yet. New articles will appear here.